epirubicin has been researched along with Lassitude in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arun, B; Babiera, GV; Basen-Engquist, K; Chaoul, A; Cohen, L; Engle, R; Hall, MH; Harrison, CA; Li, Y; Milbury, K; Perkins, GH; Shih, YT; Spelman, A; Valero, V; Wangyal, T; Wei, Q | 1 |
| Gao, X; Jing, T; Sun, Y; Wang, F; Xu, C; Zhang, C | 1 |
| Chen, S; Cui, S; Geng, C; Huang, L; Huang, T; Lei, Y; Pang, D; Shao, Z; Song, E; Tang, L; Wang, Y; Xu, B; Yang, H; Yang, W; Zhang, J; Zheng, H | 1 |
| Eggemann, H; Elling, D; Harbeck, N; Janni, W; Kaufmann, M; Kiechle, M; Kümmel, S; Loibl, S; Nekljudova, V; Sommer, H; von Minckwitz, G | 1 |
| Agrawal, S; Berger, AM; Lockhart, K | 1 |
| Botti, G; Comella, G; Comella, P; D'Aiuto, G; De Rosa, V; Di Bonito, M; Frasci, G; Iodice, G; Rubulotta, MR; Thomas, R | 1 |
| Kemeny, N; Michaelson, R; Young, C | 1 |
| Baldelli, AM; Barni, S; Casaretti, R; Cascinu, S; Catalano, G; Catalano, V; Comella, G; Frontini, L; Graziano, F; Labianca, R | 1 |
| Boogerd, W; Hamburger, HL; Muller, MJ; Schagen, SB; van Dam, FS | 1 |
2 review(s) available for epirubicin and Lassitude
| Article | Year |
|---|---|
Chemotherapy plus estramustine for management of castration-resistant prostate cancer: meta-analysis of randomized controlled trials.
Topics: Adenocarcinoma; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Combined Modality Therapy; Docetaxel; Epirubicin; Epothilones; Estramustine; Fatigue; Gastrointestinal Diseases; Hematologic Diseases; Humans; Male; Orchiectomy; Paclitaxel; Peripheral Nervous System Diseases; Prostate-Specific Antigen; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Salvage Therapy; Survival Analysis; Taxoids; Treatment Outcome; Vinblastine | 2014 |
Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cyclophosphamide; Deoxycytidine; Docetaxel; Dose-Response Relationship, Drug; Epirubicin; Fatigue; Feasibility Studies; Female; Fluorouracil; Gastrointestinal Diseases; Germany; Hematologic Diseases; Humans; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Prospective Studies; Randomized Controlled Trials as Topic; Taxoids; Vinblastine; Vinorelbine | 2008 |
6 trial(s) available for epirubicin and Lassitude
| Article | Year |
|---|---|
Randomized trial of Tibetan yoga in patients with breast cancer undergoing chemotherapy.
Topics: Actigraphy; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Doxorubicin; Epirubicin; Fatigue; Female; Fluorouracil; Humans; Male; Middle Aged; Muscle Stretching Exercises; Neoadjuvant Therapy; Neoplasm Staging; Sleep; Sleep Wake Disorders; Taxoids; Treatment Outcome; Yoga | 2018 |
Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cancer patients: a phase 2, open-label, multicenter, randomized trial.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin; Class I Phosphatidylinositol 3-Kinases; Drug Administration Schedule; Epirubicin; Fatigue; Female; Humans; Middle Aged; Nausea; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Phosphatidylinositol 3-Kinases; PTEN Phosphohydrolase; Receptor, ErbB-2; Receptors, IgG; Remission Induction; Trastuzumab; Treatment Outcome; Tumor Suppressor Protein p53 | 2015 |
Variability of patterns of fatigue and quality of life over time based on different breast cancer adjuvant chemotherapy regimens.
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Fatigue; Female; Humans; Longitudinal Studies; Middle Aged; Quality of Life; Taxoids; Time Factors; Treatment Outcome | 2009 |
Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III study.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Diarrhea; Drug Administration Schedule; Epirubicin; Fatigue; Female; Granulocyte Colony-Stimulating Factor; Humans; Kaplan-Meier Estimate; Middle Aged; Neutropenia; Paclitaxel; Patient Compliance; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Treatment Outcome | 2006 |
A phase II study of sequential chemotherapy with docetaxel after the weekly PELF regimen in advanced gastric cancer. A report from the Italian group for the study of digestive tract cancer.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Administration Schedule; Drug Therapy, Combination; Epirubicin; Fatigue; Female; Fluorouracil; Glutathione; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intravenous; Injections, Subcutaneous; Leucovorin; Male; Middle Aged; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids; Thrombocytopenia; Treatment Outcome | 2001 |
Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function.
Topics: Alpha Rhythm; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Breast Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Cognition; Cognition Disorders; Cyclophosphamide; Depression; Electroencephalography; Epirubicin; Event-Related Potentials, P300; Evoked Potentials; Fatigue; Fluorouracil; Humans; Intelligence; Least-Squares Analysis; Middle Aged; Neuropsychological Tests; Thiotepa | 2001 |
1 other study(ies) available for epirubicin and Lassitude
| Article | Year |
|---|---|
Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Colonic Neoplasms; Doxorubicin; Drug Evaluation; Epirubicin; Fatigue; Humans; Leukopenia; Middle Aged; Nausea; Rectal Neoplasms; Stereoisomerism; Vomiting | 1982 |